A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Rivaroxaban

Need help?
media.product.imagealternatetextformat.details

Rivaroxaban Impurity 80

N° de SZ CAT: SZ-R017133
Número CAS
181140-34-1
Mol.F.
C11H9NO3
Peso Molecular
203.2
Status de Fatura
In Stock
Shipping Condition Room Temperature

Nome Químico: (R)-2-(Oxiran-2-ylmethyl)isoindoline-1,3-dione

Shipping Temperature: Room Temperature

HSN Code: 38229010

Country of Origin: India

Sorrisos: O=C1N(C[C@H]2OC2)C(C3=C1C=CC=C3)=O

Rivaroxaban Impurity 80 is chemically (R)-2-(Oxiran-2-ylmethyl)isoindoline-1,3-dione. Rivaroxaban Impurity 80 is supplied with detailed characterization data compliant with regulatory guideline. Rivaroxaban Impurity 80 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rivaroxaban.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

🔍

Search by Keywords

Buy 181140-34-1 Purchase 181140-34-1 Order 181140-34-1 Enquire 181140-34-1 Price of 181140-34-1 181140-34-1 Supplier 181140-34-1 Manufacturer 181140-34-1 Exporter Buy high quality Rivaroxaban Impurity 80 Purchase Rivaroxaban Impurity 80 Rivaroxaban Impurity 80 suppliers Rivaroxaban Impurity 80 manufacturers Rivaroxaban Impurity 80 price Rivaroxaban Impurity 80 exporter Order Rivaroxaban Impurity 80 Enquire Rivaroxaban Impurity 80 Rivaroxaban Impurity 80 cost Rivaroxaban Impurity 80 Supplier Rivaroxaban Impurity 80 Distributor
ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new development or finding in product specification without further noticed.

,